Richard Kirk
CEO
Martin has a background in polymer engineering specialising in product and process development that started in ophthalmic manufacturing, including the development of early intraocular implant lenses that transformed cataract treatment. Martin joined the PolyPhotonix board at the research stage of Noctura 400 taking the solid science through product development, clinical validation, and regulatory approval for widespread market access in high volume to benefit as many patients as possible.
CEO
Quality & Regulatory Manager
Clinical Operations Manager